Efflux of tenofovir by the multidirug resistance-associated protein 4 (MRP4) is not affected by HIV protease inhibitors

被引：0
|
作者：
Ray, AS [1 ]
Vela, JE [1 ]
Robinson, KL [1 ]
Cihlar, T [1 ]
Rhodes, GR [1 ]
机构：
[1] Gilead Sci Inc, Foster City, CA 94404 USA
来源：
ANTIVIRAL THERAPY | 2005年 / 10卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：L54 / L55
页数：2
相关论文
共 50 条
  • [21] Impact of basolateral multidrug resistance-associated protein (Mrp) 3 and Mrp4 on the hepatobiliary disposition of fexofenadine in perfused mouse livers
    Tian, Xianbin
    Swift, Brandon
    Zamek-Gliszczynski, Maciej J.
    Belinsky, Martin G.
    Kruh, Gary D.
    Brouwer, Kim L. R.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (05) : 911 - 915
  • [22] Dual Role of cAMP in the Transcriptional Regulation of Multidrug Resistance-Associated Protein 4 (MRP4) in Pancreatic Adenocarcinoma Cell Lines
    Carozzo, Alejandro
    Diez, Federico
    Gomez, Natalia
    Cabrera, Maia
    Shayo, Carina
    Davio, Carlos
    Fernandez, Natalia
    PLOS ONE, 2015, 10 (03):
  • [23] Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules
    Russel, Frans G. M.
    Koenderink, Jan B.
    Masereeuw, Rosafinde
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (04) : 200 - 207
  • [24] Human multidrug resistance protein 4 (MRP4) is a cellular efflux transporter for paracetamol glutathione and cysteine conjugates
    Jan B. Koenderink
    Jeroen J. M. W. van den Heuvel
    Ab Bilos
    Galvin Vredenburg
    Nico P. E. Vermeulen
    Frans G. M. Russel
    Archives of Toxicology, 2020, 94 : 3027 - 3032
  • [25] Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)mediated efflux of cAMP and resistance to purine analogues
    Lai, LQ
    Tan, TM
    BIOCHEMICAL JOURNAL, 2002, 361 (03) : 497 - 503
  • [26] Human multidrug resistance protein 4 (MRP4) is a cellular efflux transporter for paracetamol glutathione and cysteine conjugates
    Koenderink, Jan B.
    van den Heuvel, Jeroen J. M. W.
    Bilos, Ab
    Vredenburg, Galvin
    Vermeulen, Nico P. E.
    Russel, Frans G. M.
    ARCHIVES OF TOXICOLOGY, 2020, 94 (09) : 3027 - 3032
  • [27] Missense mutations in the multidrug resistance-associated protein 2 (MRP2/ABCC2) and 4 (MRP4/ABCC4):: impact on protein expression and drug tansport
    Lang, T.
    Janke, D.
    Mehralivand, S.
    Shamsinejad, M.
    Strand, D.
    Goedtel-Armbrust, U.
    Habermeier, A.
    Gradhand, U.
    Fischer, C.
    Toliat, M. R.
    Fritz, P.
    Zanger, U. M.
    Schwab, M.
    Fromm, M. F.
    Nuernberg, P.
    Closs, E. I.
    Wojnowski, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 377 - 377
  • [28] Targeting multidrug resistance - associated protein 4 (MRP4/ABCC4) in pancreatic cancer
    May, M.
    Alejandro, C.
    Gomez, N.
    Diez, F.
    Copsel, S.
    Iturbe, J.
    Mohr, N.
    Fernandez, N.
    Shayo, C.
    Davio, C.
    ANNALS OF ONCOLOGY, 2016, 27 : 6 - 7
  • [29] Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes
    Sassi, Yassine
    Abi-Gerges, Aniella
    Fauconnier, Jeremy
    Mougenot, Nathalie
    Reiken, Steven
    Haghighi, Kobra
    Kranias, Evangelia G.
    Marks, Andrew R.
    Lacampagne, Alain
    Engelhardt, Stefan
    Hatem, Stephane N.
    Lompre, Anne-Marie
    Hulot, Jean-Sebastien
    FASEB JOURNAL, 2012, 26 (03): : 1009 - 1017
  • [30] The efflux protein MRP4 controls cAMP homeostasis in cardiac myocytes
    Sassi, Y.
    Abi-gerges, A.
    Ahles, A.
    Hatem, S.
    Hulot, J-S
    Lompre, A-M
    Engelhardt, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 71 - 71
12345